Pancreatic Polypeptide

Pancreatic Polypeptide is a hormone produced by the pancreas that plays a crucial role in regulating various digestive processes and energy balance within the body. Its discovery and subsequent research have shed light on the intricate mechanisms governing our metabolism.

Pancreatic Polypeptide

Key Takeaways

  • Pancreatic Polypeptide (PP) is a hormone secreted by specific cells in the pancreas.
  • It primarily functions to regulate digestive processes, including gastric emptying and gallbladder contraction.
  • PP also plays a significant role in appetite control and energy homeostasis.
  • Its release is typically stimulated by food intake, particularly protein-rich meals.
  • Abnormal levels of PP can sometimes indicate underlying pancreatic or metabolic conditions.

What is Pancreatic Polypeptide (PP)?

Pancreatic Polypeptide (PP) is a 36-amino acid peptide hormone primarily secreted by PP cells, also known as F cells, located within the islets of Langerhans in the pancreas. These cells constitute a small percentage of the total islet cell mass. The secretion of PP is part of the complex endocrine function of the pancreas, which also produces hormones like insulin and glucagon. PP was first isolated from bovine pancreas in 1975, and its presence has since been confirmed in various species, including humans. It is released into the bloodstream in response to several stimuli, most notably after a meal, particularly one rich in protein.

The precise mechanisms of PP synthesis and release are tightly regulated by both neural and hormonal factors. Vagal nerve stimulation, for instance, is a potent activator of PP secretion, highlighting the close interplay between the nervous system and digestive hormone regulation. The hormone circulates in the blood and acts on target cells through specific receptors, contributing to the overall orchestration of post-meal metabolic responses. Understanding what is Pancreatic Polypeptide is fundamental to appreciating its broader physiological impact.

Pancreatic Polypeptide Function and Role

The primary pancreatic polypeptide function revolves around the regulation of digestive processes and energy balance. It acts as a satiety signal, helping to modulate appetite and food intake. This makes its pancreatic polypeptide role significant in preventing overeating and maintaining a healthy weight. When released after a meal, this pancreatic polypeptide hormone exerts several inhibitory effects on the gastrointestinal system, which are crucial for efficient digestion and nutrient absorption.

Key functions of Pancreatic Polypeptide include:

  • Inhibition of Pancreatic Exocrine Secretion: PP reduces the secretion of digestive enzymes and bicarbonate from the exocrine pancreas, allowing for more controlled digestion.
  • Slowing of Gastric Emptying: By reducing the rate at which food leaves the stomach, PP helps to prolong the feeling of fullness and optimize nutrient absorption in the small intestine.
  • Inhibition of Gallbladder Contraction: PP can decrease the contraction of the gallbladder, thereby regulating the release of bile into the duodenum.
  • Appetite Regulation: It contributes to the feeling of satiety, potentially influencing long-term energy homeostasis.

The release of PP is often used as a marker for vagal nerve activity, as its secretion is highly dependent on intact vagal innervation. Disruptions in PP levels, either too high or too low, can be indicative of various conditions. For example, elevated levels may be seen in certain pancreatic tumors (e.g., PPomas), while reduced responses can occur in conditions affecting the autonomic nervous system or the pancreas itself. Its multifaceted actions underscore its importance as a key player in the complex network of hormones that govern digestion and metabolism.

[EN] Cancer Types

Cancer Clinical Trial Options

Specialized matching specifically for oncology clinical trials and cancer care research.

Your Birthday


By filling out this form, you’re consenting only to release your medical records. You’re not agreeing to participate in clinical trials yet.